Junli Feng

Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation

Emilie Seydoux, Leah J. Homad, Anna J. MacCamy et al. · Immunity · 2020 · 441 citations · Full text

Pharmacy, Immunology, Infectious Diseases +14

HGF/c-Met Acts as an Alternative Angiogenic Pathway in Sunitinib-Resistant Tumors

Farbod Shojaei, Joseph H. Lee, Brett H. Simmons et al. · Cancer Research · 2010 · 311 citations

Medicine, Oncology, Pharmacology +17

Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance

Phillip A. Schwartz, Petr Kuzmič, James Solowiej et al. · Proceedings of the National Academy of Sciences · 2013 · 281 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Insights into the Aberrant Activity of Mutant EGFR Kinase Domain and Drug Recognition

K.S. Gajiwala, Junli Feng, Rose Ann Ferre et al. · Structure · 2012 · 194 citations · Full text

Medicine, Molecular Biology, Oncology +16

Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects

Madeleine F. Jennewein, Anna J. MacCamy, Nicholas R. Akins et al. · Cell Reports · 2021 · 129 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17